SHENZHEN, China, March 06, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen specializing in cross-border logistics, today announced the appointment of Ms. HU Mengmeng as Chief Financial Officer, effective March 1, 2025. She succeeds Ms. Lin Bao, who is stepping down from her position as CFO for personal reasons. Ms. Hu (46) brings over 20 years of extensive experience in the shipping and lo ...

2024 Total Revenue of $208.4 Million Exceeds Company’s Full Year Outlook Strong Start to 2025 with Comparable Restaurant Sales for Q1 Quarter-to-Date Increasing 1% Through the End of February, a 6% Improvement Compared to Q4 2024 Company Remains on Track with New Unit Openings for 2025 CERRITOS, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner of GEN Korean BBQ, a fast-growing casual dining concept with an extensive menu and signature “gril ...

LOS ANGELES, March 06, 2025 (GLOBE NEWSWIRE) -- Stargaze Entertainment Group Inc. (“Stargaze” or the “Company”) (OTC: STGZ), a content creation and social platform designed to redefine talent discovery, today announced the closing of a private offering of 53,500,000 shares of common stock which raised $535,000. This offering was priced in October 2024 when the Company’s common stock was trading on the OTC Pink Market at a range of $0.0035 to $0.0064. About Stargaze Stargaze is a next-generation content cre ...

Core Insights - Atea Pharmaceuticals has successfully completed an End-of-Phase 2 meeting with the FDA and is set to begin patient enrollment for its global Phase 3 program for Hepatitis C Virus (HCV) in April 2025 [1][4][3] - The company aims to evaluate the efficacy of its regimen consisting of bemnifosbuvir and ruzasvir, which has shown promising results in previous trials [3][5] - Atea's strategic initiatives include exploring partnerships to enhance shareholder value and implementing cost-cutting measures to improve operational efficiency [3][12] Company Updates - Atea reported a significant reduction in cash reserves, with cash, cash equivalents, and marketable securities totaling $454.7 million as of December 31, 2024, down from $578.1 million a year earlier [14][23] - Research and development expenses for the fourth quarter and full year 2024 were $25.7 million and $144.1 million, respectively, compared to $35.0 million and $114.2 million in 2023, indicating a strategic shift in spending [15] - The company has appointed Arthur S. Kirsch to its Board of Directors, bringing extensive experience in investment banking and strategic advisory [13] Clinical Development - The Phase 2 study of bemnifosbuvir and ruzasvir met its primary endpoints, achieving a 98% sustained virologic response (SVR12) rate in treatment-adherent patients after eight weeks [8][9] - Atea plans to conduct two open-label Phase 3 trials, one in the US and Canada and another outside North America, each enrolling approximately 800 treatment-naïve patients [5][6] - The primary endpoint for the Phase 3 trials will be SVR12, measured 12 weeks post-treatment, ensuring consistency across patient evaluations [6] Market Context - The global HCV market is estimated to be approximately $3 billion in annual net sales, with around 50 million people living with untreated HCV globally, including up to 4 million in the US [3][26] - Chronic HCV infection remains a leading cause of liver disease, with significant healthcare implications despite the availability of direct-acting antivirals [26][25]

Enhancing Scalability and Performance with High-Density Cryogenic Cabling SolutionsLIVERMORE, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leader in precision test and measurement solutions, and Delft Circuits, an innovator in high-density cryogenic cabling solutions, have teamed up to integrate Delft Circuits’ Cri/oFlex® product portfolio into FormFactor’s cryogenic test systems. This partnership addresses the growing demand for scalable, high-density interconnect solutions ...

Strong unlevered balance sheet with $70.1 million in cash and no debtRepurchased $8.1 million of common stock in 2024Increased refrigerant reclamation volume by 18% in 2024 WOODCLIFF LAKE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) announced results for the fourth quarter and year ended December 31, 2024. Brian F. Coleman, President and Chief Executive Officer of Hudson Technologies, commented, “Our fourth quarter 2024 results reflected the seasonally slower sales acti ...

Company to Host Conference Call Today at 4:30 PM Eastern TimeLAKEWOOD, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today provided a business update and reported financial results for the year ended December 31, 2024. “We are pleased to report continued revenue growth and strong operational execution in 2024,” said Ezra Beyman, Chairman and Chief Executive Officer of Reliance. “This year has been truly transformative for Reliance, dr ...

BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) today announced financial results for the fourth quarter and fiscal year ended December 31, 2024, and provided a 2025 business outlook. Key highlights for the fourth quarter of 2024 compared to the fourth quarter of 2023 include: Total revenue decreased 2.0% to $121.8 million from $124.3 million.Comparable restaurant sales increased 0.8% system-wide, including a 0.5% increase for company-owned restaurants and a 1.9% incre ...

Board of Directors Declared Total Dividends of $0.54 per Share for First Quarter 2025 Base Dividend of $0.43 and Supplemental Dividend of $0.11 Per Share EVANSTON, Ill, March 06, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”), a provider of customized debt and equity financing solutions, primarily to lower middle-market companies based in the United States, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Four ...

PETAH-TIKVA, Israel, March 06, 2025 (GLOBE NEWSWIRE) -- Global-e (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will host its 2025 Investor Day on Tuesday, March 11, 2025, beginning at 9:30 a.m. ET. A live webcast of the event will be available in the Investor Relations section of Global-e’s website at https://investors.global-e.com/news-events/events-presentations. A replay of the webcast will also be available on the website after the event. About Global-e O ...